Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v6-FR
Language French French
Date Updated 2018-06-08 2018-05-17
Drug Identification Number 02468425 02468425
Brand name SHINGRIX SHINGRIX
Common or Proper name Herpes Zoster vaccine Herpes Zoster vaccine
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
Strength(s) 50MCG 50MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's 1's
ATC code J07BK J07BK
ATC description
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-30 2018-04-30
Estimated end date 2018-06-15 2018-06-15
Actual end date 2018-06-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Most recent supply released May 15, 2018 with limited quantity. SHINGRIX is available in packages of 10. Most recent supply released May 15, 2018 with limited quantity. SHINGRIX is available in packages of 10.
Health Canada comments